APA (7th ed.) Citation

D, B., R, M., Y, M., Q, L., C, S., W, H., . . . C, K. (2025). Predicting Residual 21-Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy. CPT: pharmacometrics & systems pharmacology, 14(11), 1869. https://doi.org/10.1002/psp4.70086

Chicago Style (17th ed.) Citation

D, Bindellini, Michelet R, Mirasbekov Y, Lao Q, Sukin C, Huisinga W, Merke DP, and Kloft C. "Predicting Residual 21-Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy." CPT: Pharmacometrics & Systems Pharmacology 14, no. 11 (2025): 1869. https://doi.org/10.1002/psp4.70086.

MLA (9th ed.) Citation

D, Bindellini, et al. "Predicting Residual 21-Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy." CPT: Pharmacometrics & Systems Pharmacology, vol. 14, no. 11, 2025, p. 1869, https://doi.org/10.1002/psp4.70086.